NIT
ADPT icon

NumerixS Investment Technologies’s Adaptive Biotechnologies ADPT Stock Holding History

NumerixS Investment Technologies’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-409
Closed -$11K – 1047
2020
Q1 		$11K Buy
+409
New +$11.4K 0.01% 876

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

NumerixS Investment Technologies's ADPT Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Adaptive Biotechnologies (ADPT) in Q2 2020, closing a stake of 409 shares — an estimated $11K sold.

NumerixS Investment Technologies first reported a position in ADPT in Q1 2020 and held it in 1 quarter. The position peaked at $11K in Q1 2020. 196 funds tracked by Wall St. Rank hold ADPT as of Q2 2020.

  • NumerixS Investment Technologies reported no remaining Adaptive Biotechnologies position as of Q2 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 409 Adaptive Biotechnologies shares in Q2 2020, an estimated $11K.
  • NumerixS Investment Technologies first reported a position in Adaptive Biotechnologies in Q1 2020 and held it in 1 quarter.
  • NumerixS Investment Technologies's Adaptive Biotechnologies position peaked at $11K in Q1 2020.
  • 196 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.